Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- KC +7.5%, EL +6.5%, YMM +2.4%, KEYS +2.3%, FLNG +1.7%, ADI +1.6%, VIK +1.4%, TOL +1.3%, WB +1.2%, JKHY +1.1%, SQM +0.9%, ENVX +0.8%
Other news:
- MRNA +53.1% (Merck, Moderna say Phase 3 intismeran plus KEYTRUDA met RFS, DMFS endpoints in adjuvant melanoma)
- MRK +5.8% (Merck, Moderna say Phase 3 intismeran plus KEYTRUDA met RFS, DMFS endpoints in adjuvant melanoma)
- SKHY +3.9% (approves KRW40 trln share repurchase and cancellation program)
- PPC +3.5% (JBS proposes acquiring remaining Pilgrim's Pride (PPC) shares in stock deal)
- TWST +3.3% (Anthropic has chosen Twist Bioscience Corporation as one of its independent evaluators)
- AMLX +3.1% (launches $350 mln stock offering)
- KEN +2.3% (announces receipt of approximately $93 million in connection with payment of arbitration award by the Republic of Peru)
- HYMC +1.5% (additional drill results from Brimstone and Vortex)